Cliff Asness’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $830K | Sell |
145,600
-39,394
| -21% | -$170K | ﹤0.01% | 3109 |
|
|
2026
Q1 | $716K | Sell |
184,994
-1,406
| -0.8% | -$5.77K | ﹤0.01% | 2952 |
|
|
2025
Q4 | $779K | Buy |
186,400
+79,939
| +75% | +$309K | ﹤0.01% | 2689 |
|
|
2025
Q3 | $350K | Sell |
106,461
-11,205
| -10% | -$31.6K | ﹤0.01% | 3006 |
|
|
2025
Q2 | $167K | Buy |
117,666
+54,487
| +86% | +$77.4K | ﹤0.01% | 3095 |
|
|
2025
Q1 | $94.1K | Buy |
63,179
+43,245
| +217% | +$68.1K | ﹤0.01% | 3023 |
|
|
2024
Q4 | $22.3K | Buy |
19,934
+4,041
| +25% | +$3.45K | ﹤0.01% | 2842 |
|
|
2024
Q3 | $15.1K | Sell |
15,893
-34,109
| -68% | -$43K | ﹤0.01% | 2743 |
|
|
2024
Q2 | $79K | Buy |
50,002
+18,097
| +57% | +$26.3K | ﹤0.01% | 2514 |
|
|
2024
Q1 | $46.3K | Buy |
+31,905
| New | +$45.8K | ﹤0.01% | 2378 |
|
|
2023
Q4 | – | Sell |
-86,614
| Closed | -$123K | – | 2418 |
|
|
2023
Q3 | $123K | Sell |
86,614
-56,222
| -39% | -$79.7K | ﹤0.01% | 2207 |
|
|
2023
Q2 | $164K | Sell |
142,836
-212,629
| -60% | -$251K | ﹤0.01% | 2103 |
|
|
2023
Q1 | $377K | Sell |
355,465
-191,431
| -35% | -$276K | ﹤0.01% | 1869 |
|
|
2022
Q4 | $831K | Sell |
546,896
-72,490
| -12% | -$125K | ﹤0.01% | 1619 |
|
|
2022
Q3 | $1.31M | Buy |
619,386
+130,585
| +27% | +$275K | ﹤0.01% | 1399 |
|
|
2022
Q2 | $655K | Buy |
488,801
+219,599
| +82% | +$326K | ﹤0.01% | 1583 |
|
|
2022
Q1 | $568K | Buy |
269,202
+52,028
| +24% | +$127K | ﹤0.01% | 1773 |
|
|
2021
Q4 | $806K | Buy |
217,174
+143,992
| +197% | +$620K | ﹤0.01% | 1655 |
|
|
2021
Q3 | $365K | Buy |
73,182
+22,021
| +43% | +$127K | ﹤0.01% | 1979 |
|
|
2021
Q2 | $334K | Sell |
51,161
-35,213
| -41% | -$246K | ﹤0.01% | 2020 |
|
|
2021
Q1 | $595K | Buy |
+86,374
| New | +$730K | ﹤0.01% | 1772 |
|
|
2017
Q1 | – | Sell |
-166,126
| Closed | -$4M | – | 2237 |
|
|
2016
Q4 | $4M | Sell |
166,126
-957,700
| -85% | -$26.7M | 0.01% | 1125 |
|
|
2016
Q3 | $31.2M | Sell |
1,123,826
-279,903
| -20% | -$7.4M | 0.05% | 475 |
|
|
2016
Q2 | $34.2M | Buy |
1,403,729
+948,054
| +208% | +$26.9M | 0.06% | 425 |
|
|
2016
Q1 | $15.3M | Sell |
455,675
-343,837
| -43% | -$10.8M | 0.03% | 600 |
|
|
2015
Q4 | $23.9M | Buy |
799,512
+585,330
| +273% | +$19.7M | 0.04% | 505 |
|
|
2015
Q3 | $6.75M | Buy |
214,182
+157,155
| +276% | +$7.67M | 0.01% | 713 |
|
|
2015
Q2 | $2.76M | Buy |
57,027
+51,377
| +909% | +$2.17M | 0.01% | 1045 |
|
|
2015
Q1 | $245K | Buy |
+5,650
| New | +$203K | ﹤0.01% | 1951 |
|
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Cliff Asness's PGEN Position: Q2 2026 in Review
Cliff Asness reduced its Precigen (PGEN) stake by 21% in Q2 2026, selling an estimated $170K and leaving 145,600 shares worth $830K. The position accounts for ﹤0.01% of the portfolio, ranked #3109.
Cliff Asness first reported a position in PGEN in Q1 2015 and has held it in 29 quarters since. The position peaked at $34.2M in Q2 2016. 209 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Cliff Asness held 145,600 shares of Precigen worth $830K as of Q2 2026.
- Cliff Asness sold 39,394 Precigen shares in Q2 2026, an estimated $170K.
- Precigen made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3109 holding.
- Cliff Asness first reported a position in Precigen in Q1 2015 and has held it in 29 quarters since.
- Cliff Asness's Precigen position peaked at $34.2M in Q2 2016.
- 209 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.